1 – 14 of 14
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets
(
- Contribution to journal › Article
-
Mark
GPR162 is a beta cell CART receptor
(
- Contribution to journal › Article
- 2022
-
Mark
Islet Gene View-a tool to facilitate islet research
(
- Contribution to journal › Article
-
Mark
Overexpressed beta cell CART increases insulin secretion in mouse models of insulin resistance and diabetes
(
- Contribution to journal › Article
- 2019
-
Mark
Defective exocytosis and processing of insulin in a cystic fibrosis mouse model
(
- Contribution to journal › Article
- 2017
-
Mark
Nuclear import of glucokinase in pancreatic beta-cells is mediated by a nuclear localization signal and modulated by SUMOylation
(
- Contribution to journal › Article
-
Mark
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Genetic determinants of circulating GIP and GLP-1 concentrations
(
- Contribution to journal › Article
-
Mark
Parent-of-origin effects on gene expression in trios with type 2 diabetic offspring
2017)(
- Contribution to conference › Poster
- 2016
-
Mark
HMGB1 binds to the rs7903146 locus in TCF7L2 in human pancreatic islets.
(
- Contribution to journal › Article
-
Mark
L24 The effect of ghrelin administration in the R6/2 mouse model of Huntington’s disease
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
(
- Contribution to journal › Article
- 2014
-
Mark
TCF7L2 is a master regulator of insulin production and processing.
(
- Contribution to journal › Article
- 2005
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article